The Effect of Fosgonimeton on Alzheimer's Disease Neuroprotection and Cognition.

Published Date: 16 Nov 2023

Chief scientific officer of Athira Pharma Kevin Church, PhD, presented preclinical results of fosgonimeton at CTAD 2023, showing procognitive effects of the therapy in mice models of Alzheimer disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

2.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

3.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

4.

Ketamine plus psychotherapy for "excellent" PTSD

5.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot